SkinBioTherapeutics Plc announced that further to the announcement of 28 March 2022, the proposed appointments of Danielle Bekker as non-executive director have been approved by the Company's AIM Nominated Adviser. Danielle Bekker will commence in the role of non-executive director immediately.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.75 GBX | 0.00% | -1.27% | -36.07% |
Jun. 18 | EARNINGS AND TRADING: Cordel thrilled by Middle East contract win | AN |
Apr. 05 | SkinBioTherapeutics Gets Bond Conversion Notice from Macquarie | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-36.07% | 23.85M | |
+14.84% | 121B | |
+18.31% | 112B | |
+2.94% | 22.72B | |
-18.26% | 20.82B | |
-18.47% | 16.66B | |
-42.36% | 16.36B | |
-14.23% | 16.19B | |
-0.68% | 13.17B | |
+21.87% | 11.11B |
- Stock Market
- Equities
- SBTX Stock
- News SkinBioTherapeutics plc
- SkinBioTherapeutics Plc Announces Appointment of Danielle Bekker as Non-Executive Director